Automatic Machine Learning to Differentiate Pediatric Posterior Fossa Tumors on Routine MR Imaging

References

1. 1.↵
   1. Curtin SC,
   2. Miniño AM,
   3. Anderson RN

   . National Center for Health Statistics. Declines in cancer death rates among children and adolescents in the United States, 1999–2014. NCHS data brief, no 257, Sept 2016. https://www.cdc.gov/nchs/products/databriefs/db257.htm. Accessed March 21, 2020
2. 2.↵
   1. Brandão LA,
   2. Poussaint TY

   . Posterior fossa tumors. Neuroimaging Clin N Am 2017;27:1–37 doi:10.1016/j.nic.2016.08.001 pmid:27889018

   CrossRefPubMed
3. 3.↵
   1. O’Brien D,
   2. Caird J,
   3. Kennedy M, et al

   . Posterior fossa tumours in childhood: evaluation of presenting clinical features. Ir Med J 2001;94:52–53 pmid:11321174

   PubMed
4. 4.↵
   1. Prasad KS,
   2. Ravi D,
   3. Pallikonda V, et al

   . Clinicopathological study of pediatric posterior fossa tumors. J Pediatr Neurosci 2017;12:245–50 doi:10.4103/jpn.JPN_113_16 pmid:29204199

   CrossRefPubMed
5. 5.↵
   1. Bidiwala S,
   2. Pittman T

   . Neural network classification of pediatric posterior fossa tumors using clinical and imaging data. Pediatr Neurosurg 2004;40:8–15 doi:10.1159/000076571 pmid:15007223

   CrossRefPubMed
6. 6.↵
   1. Becker LE

   . Pathology of pediatric brain tumors. Neuroimaging Clin N Am 1999;9:671–90 pmid:10517939

   PubMed
7. 7.↵
   1. Rizzo S,
   2. Botta F,
   3. Raimondi S, et al

   . Radiomics: the facts and the challenges of image analysis. Eur Radiol Exp 2018;2:36 doi:10.1186/s41747-018-0068-z pmid:30426318

   CrossRefPubMed
8. 8.↵
   1. Gillies RJ,
   2. Kinahan PE,
   3. Hricak H

   . Radiomics: images are more than pictures, they are data. Radiology 2016;278:563–77 doi:10.1148/radiol.2015151169 pmid:26579733

   CrossRefPubMed
9. 9.↵
   1. Fan Y,
   2. Chen C,
   3. Zhao F, et al

   . Radiomics-based machine learning technology enables better differentiation between glioblastoma and anaplastic oligodendroglioma. Front Oncol 2019;9:1164 doi:10.3389/fonc.2019.01164 pmid:31750250

   CrossRefPubMed
10. 10.↵
    1. Chen C,
    2. Ou X,
    3. Wang J, et al

    . Radiomics-based machine learning in differentiation between glioblastoma and metastatic brain tumors. Front Oncol 2019;9: 806 doi:10.3389/fonc.2019.00806 pmid:31508366

    CrossRefPubMed
11. 11.↵
    1. Sidey-Gibbons JA,
    2. Sidey-Gibbons CJ

    . Machine learning in medicine: a practical introduction. BMC Med Res Methodol 2019;19:64 doi:10.1186/s12874-019-0681-4 pmid:30890124

    CrossRefPubMed
12. 12.↵
    1. Parmar C,
    2. Grossmann P,
    3. Bussink J, et al

    . Machine learning methods for quantitative radiomic biomarkers. Sci Rep 2015;5:13087 doi:10.1038/srep13087 pmid:26278466

    CrossRefPubMed
13. 13.↵
    1. Olson R,
    2. Urbanowicz R,
    3. Andrews P, et al

    . Automating biomedical data science through tree-based pipeline optimization. In: Proceedings of the 19th European Conference, EvoApplications 2016, Porto, Portugal; March 30 to April 1, 2016
14. 14.↵
    1. Le TT,
    2. Fu W,
    3. Moore JH

    . Scaling tree-based automated machine learning to biomedical big data with a feature set selector. Bioinformatics 2020;36:250–56 doi:10.1093/bioinformatics/btz470 pmid:31165141

    CrossRefPubMed
15. 15.↵
    1. Zwanenburg A,
    2. Vallieres M,
    3. Abdalah MA, et al

    . The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology 2020;295:328–38 doi:10.1148/radiol.2020191145 pmid:32154773

    CrossRefPubMed
16. 16.↵
    1. Vallieres M,
    2. Kay-Rivest E,
    3. Perrin LJ, et al

    . Radiomics strategies for risk assessment of tumour failure in head-and-neck cancer. Sci Rep 2017;7:10117 doi:10.1038/s41598-017-10371-5 pmid:28860628

    CrossRefPubMed
17. 17.↵
    1. Olson RS,
    2. Urbanowicz RJ,
    3. Andrews PC, et al

    . Automating biomedical data science through tree-based pipeline optimization. In: Proceedings of the 19th European Conference, EvoApplications 2016; Porto, Portugal; March 30 to April 1, 2016
18. 18.↵
    1. Van Asch V

    . Macro-and micro-averaged evaluation measures [BASIC DRAFT]. https://pdfs.semanticscholar.org/1d10/6a2730801b6210a67f7622e4d192bb309303.pdf. Accessed March 21, 2020
19. 19.↵
    1. Agresti A,
    2. Coull BA

    . Approximate is better than “exact” for interval estimation of binomial proportions. The American Statistician 1998;52:119–26 doi:10.1080/00031305.1998.10480550

    CrossRefWeb of Science
20. 20.↵
    1. Poretti A,
    2. Meoded A,
    3. Huisman TA

    . Neuroimaging of pediatric posterior fossa tumors including review of the literature. J Magn Reson Imaging 2012;35:32–47 doi:10.1002/jmri.22722 pmid:21989968

    CrossRefPubMed
21. 21.↵
    1. Kerleroux B,
    2. Cottier JP,
    3. Janot K, et al

    . Posterior fossa tumors in children: radiological tips & tricks in the age of genomic tumor classification and advance MR technology. J Neuroradiol 2020;47:46–53 doi:10.1016/j.neurad.2019.08.002 pmid:31541639

    CrossRefPubMed
22. 22.↵
    1. Pierce T,
    2. Kranz PG,
    3. Roth C, et al

    . Use of apparent diffusion coefficient values for diagnosis of pediatric posterior fossa tumors. Neuroradiol J 2014;27:233–44 doi:10.15274/NRJ-2014-10027 pmid:24750714

    CrossRefPubMed
23. 23.↵
    1. Zitouni S,
    2. Koc G,
    3. Doganay S, et al

    . Apparent diffusion coefficient in differentiation of pediatric posterior fossa tumors. Jpn J Radiol 2017;35:448–53 doi:10.1007/s11604-017-0652-9 pmid:28550357

    CrossRefPubMed
24. 24.↵
    1. Rumboldt Z,
    2. Camacho DL,
    3. Lake D, et al

    . Apparent diffusion coefficients for differentiation of cerebellar tumors in children. AJNR Am J Neuroradiol 2006;27:1362–69 pmid:16775298

    Abstract/FREE Full Text
25. 25.↵
    1. Gimi B,
    2. Cederberg K,
    3. Derinkuyu B, et al

    . Utility of apparent diffusion coefficient ratios in distinguishing common pediatric cerebellar tumors. Acad Radiol 2012;19:794–800 doi:10.1016/j.acra.2012.03.004 pmid:22513110

    CrossRefPubMed
26. 26.↵
    1. Koral K,
    2. Alford R,
    3. Choudhury N, et al

    . Applicability of apparent diffusion coefficient ratios in preoperative diagnosis of common pediatric cerebellar tumors across two institutions. Neuroradiology 2014;56:781–88 doi:10.1007/s00234-014-1398-z pmid:24974083

    CrossRefPubMed
27. 27.↵
    1. Jaremko JL,
    2. Jans LB,
    3. Coleman LT, et al

    . Value and limitations of diffusion-weighted imaging in grading and diagnosis of pediatric posterior fossa tumors. AJNR Am J Neuroradiol 2010;31:1613–16 doi:10.3174/ajnr.A2155 pmid:20538820

    Abstract/FREE Full Text
28. 28.↵
    1. Schneider JF,
    2. Confort-Gouny S,
    3. Viola A, et al

    . Multiparametric differentiation of posterior fossa tumors in children using diffusion-weighted imaging and short echo-time 1H-MR spectroscopy. J Magn Reson Imaging 2007;26:1390–98 doi:10.1002/jmri.21185 pmid:17968955

    CrossRefPubMed
29. 29.↵
    1. Rodriguez Gutierrez D,
    2. Awwad A,
    3. Meijer L, et al

    . Metrics and textural features of MRI diffusion to improve classification of pediatric posterior fossa tumors. AJNR Am J Neuroradiol 2014;35:1009–15 doi:10.3174/ajnr.A3784 pmid:24309122

    Abstract/FREE Full Text
30. 30.↵
    1. Orlenko A,
    2. Moore JH,
    3. Orzechowski P, et al

    . Considerations for automated machine learning in clinical metabolic profiling: altered homocysteine plasma concentration associated with metformin exposure. Pac Symp Biocomput 2018;23: 460–71 pmid:29218905

    PubMed
31. 31.↵
    1. Su X,
    2. Chen N,
    3. Sun H, et al

    . Automated machine learning based on radiomics features predicts H3 K27M mutation in midline gliomas of the brain. Neuro Oncol 2020;22:393–401 doi:10.1093/neuonc/noz184 pmid:31563963

    CrossRefPubMed
32. 32.↵
    1. Olson RS,
    2. Cava W,
    3. Mustahsan Z, et al

    . Data-driven advice for applying machine learning to bioinformatics problems. Pac Symp Biocomput 2018;23: 192–203 pmid:29218881

    PubMed
33. 33.↵
    1. Quail DF,
    2. Joyce JA

    . The microenvironmental landscape of brain tumors. Cancer Cell 2017;31:326–41 doi:10.1016/j.ccell.2017.02.009 pmid:28292436

    CrossRefPubMed
34. 34.↵
    1. Massimino M,
    2. Cefalo G,
    3. Riva D, et al

    . Long-term results of combined preradiation chemotherapy and age-tailored radiotherapy doses for childhood medulloblastoma. J Neurooncol 2012;108:163–71 doi:10.1007/s11060-012-0822-7 pmid:22350379

    CrossRefPubMed
35. 35.↵
    1. Manias KA,
    2. Gill SK,
    3. MacPherson L, et al

    . Diagnostic accuracy and added value of qualitative radiological review of 1H-magnetic resonance spectroscopy in evaluation of childhood brain tumors. Neurooncol Pract 2019;6:428–37 doi:10.1093/nop/npz010 pmid:31832213

    CrossRefPubMed
36. 36.↵
    1. Manias K,
    2. Gill SK,
    3. Zarinabad N, et al

    . Evaluation of the added value of 1H-magnetic resonance spectroscopy for the diagnosis of pediatric brain lesions in clinical practice. Neurooncol Pract 2018;5:18–27 doi:10.1093/nop/npx005 pmid:29692921

    CrossRefPubMed